Equity

AnnouncementsHome > Equity > Corporate Actions > Announcements

It gives top daily,weekly and monthly Gainers/Losers of NSE indices on % basis in descending order. Click on company name to get the company profile page.

Exchange :
As on Jan 23, 2020 12:00 AM
Your results on  :  NSE
NSE Announcements
Alok Industries Limited
Corporate Insolvency Resolution Process ALOKTEXT : As already intimated in your Exchange, pursuant to its order dated March 08, 2019, the Hon'ble NCLT, Ahmedabad Bench had approved the resolution plan ('"Approved Resolution Plan") submitted by the Resolution Applicants for the Company under Section 31 of the Code. The purpose of this letter is to formally intimate that the implementation of the Approved Resolution Plan has now commenced.
Apar Industries Limited
Outcome of Board Meeting Outcome of Board Meeting and submission of Standalone and Consolidated Un-audited Financial results of the Company for the Third Quarter and Nine Months ended 31st December, 2019 (2019-20).
Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 23, 2020, titled "Alembic Pharmaceuticals receives USFDA Final Approval for Fenofibrate Tablets USP, 54 mg and 160 mg.".
Arrow Textiles Limited
Arrow Textiles Limitedity Shares of Arrow Textiles Limited shall be suspended w.e.f. February 6, 2020 (i.e. closing hours of trading on February 5, 2020) on account of Scheme of Amalgamation of Arrow Textiles Limited with Delta Magnets Limited.
Asian Paints Limited
Asian Paints Limited has informed the Exchange about Amalgamation/Merger Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations), we wish to inform you that the Board of Directors at their meeting held today, has inter alia, approved the Scheme of amalgamation of Reno Chemicals Pharmaceuticals & Cosmetics Private Limited ( Transferor Company ), wholly owned subsidiary of the Company with Asian Paints Limited ( Transferee Company ) in accordance with the provisions of Companies Act, 2013 and other applicable laws. The aforesaid amalgamation is subject to necessary statutory and regulatory approvals, including approval of the National Company Law Tribunal, Mumbai. The details required under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD/4/2O15 dated 9th September, 2015 are enclosed.
AstraZeneca Pharma India Limited
AstraZeneca Pharma India Limited has informed the Exchange regarding 'AstraZeneca Pharma India Limited has informed the Exchange regarding 'Pursuant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose advertisements given in Business Standard and Udayavani on January 22, 2020 in respect of Board Meeting of the Company to be held on February 3, 2020. '.
AU Small Finance Bank Limited
AU Small Finance Bank Limited has informed the Exchange regarding Investor Presentation. Presentation to Investors on Unaudited Financial Results for the Quarter and Nine Months ended on 31st December 2019
Avanti Feeds Limited
Avanti Feeds Limited has informed the Exchange regarding 'Further to our letter cited, we enclose herewith copies of News Paper clippings published on 23rd January, 2020 in Financial Express (all editions) and Andhra Prabha (Hyderabad and Visakhapatnam editions), in connection with the Board Meeting of our Company, to be held on 04.02.2020, inter alia to consider Un-audited Financial Results for the quarter ended 31st December, 2019. We request you to kindly take the above on record. '.
Axis Bank Limited
Axis Bank Limited has informed the Exchange regarding Statement of deviation(s) or variation(s) under Reg. 32 of SEBI (LODR) Regulations 2015
AXISCADES Engineering Technologies
AXISCADES Engineering Technologies Limited has informed the Exchange regarding a press release dated January 23, 2020, titled "AXISCADES delivers strong Q3 FY20 reslts".
1 2 3 4 5  ... 

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)